Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18+

SponsorInstitute of Oncology Ljubljana

About this trial

CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

Patients with inflammatory breast cancer, regardless of cancer subtype (stage IIID)

Patients with non-inflammatory breast cancer: triple-negative and HER2+ subtypes, from stage IIB to IIIA-C

Adequate health status for neoadjuvant systemic treatment

Inflammatory breast cancer stage IV

Luminal A, luminal B subtypes of non-inflammatory breast cancer

Stages I-IIA breast cancer

Inability to understand or communicate in Slovenian

130 Participants

are divided into 1 treatment group

Institute of Oncology Ljubljana

Lead sponsor